Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for EPGNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2023 4.601M
March 31, 2023 12.04M
December 31, 2022 16.92M
September 30, 2022 18.58M
June 30, 2022 21.56M
March 31, 2022 24.97M
December 31, 2021 28.05M
September 30, 2021 31.30M
June 30, 2021 11.49M
March 31, 2021 11.16M
December 31, 2020 8.316M
September 30, 2020 10.35M
June 30, 2020 12.40M
March 31, 2020 14.87M
December 31, 2019 15.70M
September 30, 2019 14.13M
June 30, 2019 17.70M
March 31, 2019 20.95M
December 31, 2018 24.95M
September 30, 2018 14.50M
June 30, 2018 16.54M
March 31, 2018 20.53M
December 31, 2017 23.74M
September 30, 2017 26.46M
June 30, 2017 14.65M
Date Value
March 31, 2017 16.41M
December 31, 2016 19.22M
September 30, 2016 13.94M
June 30, 2016 19.80M
March 31, 2016 14.65M
December 31, 2015 13.69M
September 30, 2015 15.91M
June 30, 2015 16.78M
March 31, 2015 11.33M
December 31, 2014 13.70M
September 30, 2014 9.848M
June 30, 2014 13.59M
March 31, 2014 15.81M
December 31, 2013 15.27M
September 30, 2013 8.115M
June 30, 2013 9.377M
March 31, 2013 11.78M
December 31, 2012 9.068M
September 30, 2012 13.51M
June 30, 2012 17.45M
March 31, 2012 22.04M
December 31, 2011 25.27M
September 30, 2011 33.20M
June 30, 2011 41.02M
March 31, 2011 44.25M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
CureVac NV 1.338B
PAION AG --
Veracyte, Inc. 1.436B
Bonus Biogroup Ltd. --
Quantum Cyber NV 7.718M